image
CNS Pharmaceuticals, Inc. CNSP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.1051
-11.6 %
$ 3.9 M
Market Cap
0.0
P/E
BALANCE SHEET
1.7 M ASSETS
-86.97%
Growth Rates
1Year -86.97%
3Years -52.48%
5Years 20.01%
7Years 0.00%
10Years 0.00%
6.13 M LIABILITIES
24.65%
Growth Rates
1Year 24.65%
3Years 47.65%
5Years 37.84%
7Years 0.00%
10Years 0.00%
-4.43 M EQUITY
-54.50%
Growth Rates
1Year -54.50%
3Years -9.63%
5Years -51.83%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition CNS Pharmaceuticals, Inc.
image
Current Assets 1.59 M
Cash & Short-Term Investments 549 K
Receivables 0
Other Current Assets 1.04 M
Non-Current Assets 110 K
Long-Term Investments 0
PP&E 4.93 K
Other Non-Current Assets 105 K
Current Liabilities 6.13 M
Accounts Payable 5.83 M
Short-Term Debt 301 K
Other Current Liabilities 0
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 0.5 10.1 5.0 14.0 7.2 0.3 0.1
Short Term Investments 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 1.0 5.0 2.5 1.5 0.7 0.3 51.7 K
Total Current Assets 1.6 12.6 7.5 15.5 7.9 0.6 0.2
PP&E 4.93 K 5.66 K 16.1 K 23.4 K 18.2 K 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0.1 0.5 1.3 0.3 0 95.2 K 0
Other Assets 0 0 0 0 0 0 0
Total Assets 1.7 13.1 8.8 15.9 7.9 0.7 0.2
LIABILITIES
Accounts Payable 5.8 3.7 2.0 0.9 0.3 0.1 57.5 K
Short Term Debt 0.3 0.4 0.4 0.4 0 0.3 0.1
Other Current Liabilities 0 0.8 0.2 0.5 21.5 K 0.8 41.4 K
Total Current Liabilities 6.1 4.9 2.1 1.9 0.3 1.2 0.2
Long Term Debt 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0
Total Liabilities 6.1 4.9 2.1 1.9 0.3 1.2 0.2
EQUITY
Common Stock 6.21 K 1.62 K 27.9 K 23.9 K 16.4 K 12.7 K 10.3 K
Retained Earnings (69.6) (50.7) (35.0) (20.9) (11.5) (7.6) (0.2)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0
Total Equity (4.4) 8.1 6.6 13.9 7.6 (0.5) 58.5 K
Total Liabilities and Equity 1.7 13.1 8.8 15.9 7.9 0.7 0.2
SHARES OUTSTANDING
Common Shares Outstanding 75 K 27.2 K 17 K 11 K 0 0 0